N-(3-ETHYNYLPHENYL)-6,7-BIS(2-METHOXYETHOXY)-4-QUINAZOLINAMINE FOR USE IN THE TREATMENT OF NSCLC

The invention provides a compound comprising N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine, or a pharmaceutically acceptable salt thereof in anhydrous or hydrate form for use in the treatment of NSCLC (non small cell lung cancer).

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MOYER, James, D, NORRIS, Timothy, FOSTER, Barbara, A, KAJIJI, Shama, M, MORIN, Michael, J, FERRANTE, Karen, J, SILBERMAN, Sandra, L, RAGGON, Jeffrey, W, CONNELL, Richard, D
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PERFORMING OPERATIONS PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SEPARATION SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TRANSPORTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention provides a compound comprising N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine, or a pharmaceutically acceptable salt thereof in anhydrous or hydrate form for use in the treatment of NSCLC (non small cell lung cancer).